Families First Coronavirus Response Act Signed This Week

Published in Member Communities on March 20, 2020

The Senate has passed (by a vote of 90-8), and President Trump has signed, the second COVID-19 relief package, known as the Families First Coronavirus Response Act (H.R. 6201). A full summary of the bill can be found here or the full bill here. This bill addresses several factors related to the COVID-19 outbreak, but for the healthcare/DMEPOS industry, the bill contains the following features that we believe are relevant to most of us:

  • Establishes a federal emergency paid leave benefits program to provide payments to employees taking unpaid leave due to the coronavirus outbreak (4 qualifying situations: diagnosed, quarantined, caring for diagnosed, or caring for a child due to school/daycare closure),
  • Expands unemployment benefits and provide grants to states for processing and paying claims, 
  • Requires employers with less than 500 employees to provide paid sick leave to employees (the benefits paid are not subject to federal income taxes),
  • Establishes requirements for providing coronavirus diagnostic testing at no cost to consumers,
  • Treats personal respiratory protective devices as covered countermeasures that are eligible for certain liability protections, 
  • Temporarily increases the federal medical assistance percentage (FMAP) that states receive from the federal government for their respective Medicaid programs, and
  • Requires private health plans, Medicare, Medicare Advantage, and Medicaid plans to cover testing for COVID-19 at no cost to the consumer.

The supplemental appropriations provided by the bill are designated as emergency spending, which is exempt from discretionary spending limits.

The bill also requires the Occupational Safety and Health Administration (OSHA) to issue an emergency temporary standard that requires certain employers to develop and implement a comprehensive infectious disease exposure control plan to protect health care workers.

Here is an overview of how FFCRA works. 

From Our Experts

Empowering Patients and Caregivers: Advocacy and Education thumbnail Empowering Patients and Caregivers: Advocacy and Education Whether it's a safety bed, mobility aid, or a respiratory device, healthcare providers' roles extend beyond equipment delivery—we are educators, advocates, and allies. Staffing Ratios and Compensation Insights for U.S. Rehab Members and CRT Dealers thumbnail Staffing Ratios and Compensation Insights for U.S. Rehab Members and CRT Dealers This report provides insights into team structures and pay for key roles like ATPs, service technicians, and billing personnel. Marketing: Embrace the Happy Customer thumbnail Marketing: Embrace the Happy Customer In today's hyper-connected world, customer satisfaction isn't just a metric—it's a marketing engine. A Letter From the President: July 2025 thumbnail A Letter From the President: July 2025 From evolving reimbursement models to the complexities of competitive bidding, the landscape continues to shift beneath our feet, but VGM is here for you. How the June 2025 MedPAC Report Shapes the Future of HME thumbnail How the June 2025 MedPAC Report Shapes the Future of HME The June 2025 Report to Congress from the Medicare Payment Advisory Commission (MedPAC) offers critical insights into the evolving landscape of Medicare services. While the report does not focus exclusively on home medical equipment (HME) or durable medical equipment (DME), several areas touch on themes that are highly relevant to the industry's future—particularly around home health care, Medicare Advantage (MA), and supplemental benefits. Balancing Costs and Growth: Williams Bros.' Strategies for Success thumbnail Balancing Costs and Growth: Williams Bros.' Strategies for Success Williams Bros. has been adept at managing the complexities of business expenses, improving margins, and mitigating lost opportunities. Navigating the New CMS Landscape with the HMV and RAD Decision Memo for COPD thumbnail Navigating the New CMS Landscape with the HMV and RAD Decision Memo for COPD Ronda Buhrmester, Sr. Director of Payer Relations and Reimbursement, shares insights on the newly finalized National Coverage Determination (NCD) for home mechanical ventilation (HMV) and respiratory assist devices (RAD). Balancing Costs and Growth: Williams Bros.' Strategies for Success thumbnail Balancing Costs and Growth: Williams Bros.' Strategies for Success Williams Bros. has been adept at managing the complexities of business expenses, improving margins, and mitigating lost opportunities.